Boeing Case Highlights Risk For Health, Life Sciences Boards
On Sept. 7, the Delaware Chancery Court allowed In re: The Boeing Co. Derivative Litigation to proceed, surviving a motion to dismiss.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article